In addition, patients with high TNFSF14 expression showed less alpha-fetoprotein (AFP) levels, lower ALT, lower BCLC HCC stages, and lower metastasis risk than those with low TNFSF14 expression (P < 0.05, Fig. S4). The gene discussed is AFP; the disease is hepatocellular carcinoma.